<DOC>
	<DOC>NCT00333450</DOC>
	<brief_summary>To evaluate the immunological memory against pneumococcal vaccine serotypes in children primed with conjugate vaccines by administering a booster dose of plain polysaccharide vaccine.</brief_summary>
	<brief_title>Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.</brief_title>
	<detailed_description>2 groups (60 per group), booster of Pneumovax 23 after priming with Prevnar or GSK Biologicals' pneumococcal vaccine.</detailed_description>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion: healthy children between 1114 months old who received primary vaccination with Prevnar or GSK Biologicals' pneumococcal conjugate vaccine. Exclusion: children having received or planning to receive any investigational products, vaccines not foreseen in the protocol and immune modifying drugs; children having received any additional pneumococcal vaccine than in the primary study; children with any disease that affect the immune system and history of seizures and/or allergic disease.</criteria>
	<gender>All</gender>
	<minimum_age>11 Months</minimum_age>
	<maximum_age>14 Months</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>